Jill A. Howe - Chief Financial Officer at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
LCTX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jill A. Howe since 30 Jan 2025

Holdings reported by Jill A. Howe for Lineage Cell Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 25,500 $15,045 $0.5900 26 Nov 2024 Direct
Employee Stock Option (Right to Buy) 750,000 10 Mar 2025 Direct Common Shares

Transactions reported by Jill A. Howe for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.